Glycosylation differences between the normal and pathogenic prion protein isoforms
AUTOR(ES)
Rudd, Pauline M.
FONTE
The National Academy of Sciences
RESUMO
Prion protein consists of an ensemble of glycosylated variants or glycoforms. The enzymes that direct oligosaccharide processing, and hence control the glycan profile for any given glycoprotein, are often exquisitely sensitive to other events taking place within the cell in which the glycoprotein is expressed. Alterations in the populations of sugars attached to proteins can reflect changes caused, for example, by developmental processes or by disease. Here we report that normal (PrPC) and pathogenic (PrPSc) prion proteins (PrP) from Syrian hamsters contain the same set of at least 52 bi-, tri-, and tetraantennary N-linked oligosaccharides, although the relative proportions of individual glycans differ. This conservation of structure suggests that the conversion of PrPC into PrPSc is not confined to a subset of PrPs that contain specific sugars. Compared with PrPC, PrPSc contains decreased levels of glycans with bisecting GlcNAc residues and increased levels of tri- and tetraantennary sugars. This change is consistent with a decrease in the activity of N-acetylglucosaminyltransferase III (GnTIII) toward PrPC in cells where PrPSc is formed and argues that, in at least some cells forming PrPSc, the glycosylation machinery has been perturbed. The reduction in GnTIII activity is intriguing both with respect to the pathogenesis of the prion disease and the replication pathway for prions.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=23897Documentos Relacionados
- Molecular Distinction between Pathogenic and Infectious Properties of the Prion Protein
- Membrane topology influences N-glycosylation of the prion protein
- Functional Differences between Ultrabithorax Protein Isoforms in Drosophila Melanogaster: Evidence from Elimination, Substitution and Ectopic Expression of Specific Isoforms
- Amino acid sequence homologies and glycosylation differences between the fourth component of murine complement and sex-limited protein.
- The consequences of pathogenic mutations to the human prion protein
